When looking at non-CRC GI malignancies, biliary tract cancers were found to have the highest frequency of BRAF alteration in 4.1% of patients, which is comparable to prior studies reporting a frequency of 5–7% [18]. This evidence concerns the gene BRAF and colorectal carcinoma.